Roles of Cofactors in Drug-Induced Liver Injury: Drug Metabolism and Beyond

被引:5
|
作者
Gu, Ruizhi [1 ]
Liang, Alina [2 ]
Liao, Grace [2 ]
To, Isabelle [2 ]
Shehu, Amina [1 ]
Ma, Xiaochao [1 ]
机构
[1] Univ Pittsburgh, Dept Pharmaceut Sci, Ctr Pharmacogenet, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA
基金
美国国家卫生研究院;
关键词
GLUTATHIONE-S-TRANSFERASE; ENDOTHELIAL GROWTH-FACTOR; PREGNANE X RECEPTOR; INDUCED HEPATOTOXICITY; ACETAMINOPHEN HEPATOTOXICITY; OXIDATIVE STRESS; GUT MICROBIOTA; RISK-FACTOR; MODULATES HEPATOTOXICITY; HEPATOCYTE REGENERATION;
D O I
10.1124/dmd.121.000457
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug-induced liver injury (DILI) remains one of the major concerns for healthcare providers and patients. Unfortunately, it is difficult to predict and prevent DILI in the clinic because detailed mechanisms of DILI are largely unknown. Many risk factors have been identified for both ???intrinsic??? and ???idiosyncratic??? DILI, suggesting that cofactors are an important aspect in understanding DILI. This review outlines the cofactors that potentiate DILI and categorizes them into two types: (1) the specific cofactors that target metabolic enzymes, transporters, antioxidation defense, immune response, and liver regeneration; and (2) the general cofactors that include inflammation, age, gender, comorbidity, gut microbiota, and lifestyle. The underlying mechanisms by which cofactors potentiate DILI are also discussed. SIGNIFICANCE STATEMENT This review summarizes the risk factors for DILI, which can be used to predict and prevent DILI in the clinic. This work also highlights the gaps in the DILI field and provides future perspectives on the roles of cofactors in DILI.
引用
收藏
页码:646 / 654
页数:9
相关论文
共 50 条
  • [1] Drug-Induced Liver Injury: The Role of Drug Metabolism and Transport
    Corsini, Alberto
    Bortolini, Michele
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (05) : 463 - 474
  • [2] Associations of Drug Lipophilicity and Extent of Metabolism with Drug-Induced Liver Injury
    McEuen, Kristin
    Borlak, Juergen
    Tong, Weida
    Chen, Minjun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (07)
  • [3] Pharmacogenetics of Drug-Induced Liver Injury
    Russmann, Stefan
    Jetter, Alexander
    Kullak-Ublick, Gerd A.
    HEPATOLOGY, 2010, 52 (02) : 748 - 761
  • [4] Mechanisms of drug-induced liver injury
    Stephens, Camilla
    Andrade, Raul J.
    Isabel Lucena, M.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 14 (04) : 286 - 292
  • [5] Extracellular vesicles: Roles and applications in drug-induced liver injury
    Umbaugh, David S.
    Jaeschke, Hartmut
    ADVANCES IN CLINICAL CHEMISTRY, VOL 102, 2021, 102 : 63 - 125
  • [6] Drug-induced liver injury
    Andrade, Raul J.
    Chalasani, Naga
    Bjornsson, Einar S.
    Suzuki, Ayako
    Kullak-Ublick, Gerd A.
    Watkins, Paul B.
    Devarbhavi, Harshad
    Merz, Michael
    Isabel Lucena, M.
    Kaplowitz, Neil
    Aithal, Guruprasad P.
    NATURE REVIEWS DISEASE PRIMERS, 2019, 5 (1)
  • [7] Drug-Induced Liver Injury
    Leise, Michael D.
    Poterucha, John J.
    Talwalkar, Jayant A.
    MAYO CLINIC PROCEEDINGS, 2014, 89 (01) : 95 - 106
  • [8] A review of drug-induced liver injury databases
    Luo, Guangwen
    Shen, Yiting
    Yang, Lizhu
    Lu, Aiping
    Xiang, Zheng
    ARCHIVES OF TOXICOLOGY, 2017, 91 (09) : 3039 - 3049
  • [9] Drug-induced liver injury: Is it somehow foreseeable?
    Tarantino, Giovanni
    Di Minno, Matteo Nicola Dario
    Capone, Domenico
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (23) : 2817 - 2833
  • [10] Biochemical mechanisms in drug-induced liver injury: Certainties and doubts
    Grattagliano, Ignazio
    Bonfrate, Leonilde
    Diogo, Catia V.
    Wang, Helen H.
    Wang, David Q. H.
    Portincasa, Piero
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (39) : 4865 - 4876